Literature DB >> 16287976

MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function.

David T Humphreys1, Belinda J Westman, David I K Martin, Thomas Preiss.   

Abstract

MicroRNAs (miRNAs) repress translation of target mRNAs by interaction with partially mismatched sequences in their 3' UTR. The mechanism by which they act on translation has remained largely obscure. We examined the translation of mRNAs containing four partially mismatched miRNA-binding sites in the 3' UTR in HeLa cells cotransfected with a cognate miRNA. The mRNAs were prepared by in vitro transcription and were engineered to employ different modes of translation initiation. We find that the 5' cap structure and the 3' poly(A) tail are each necessary but not sufficient for full miRNA-mediated repression of mRNA translation. Replacing the cap structure with an internal ribosome entry site from either the cricket paralysis virus or the encephalomyocarditis virus impairs miRNA-mediated repression. Collectively, these results demonstrate that miRNAs interfere with the initiation step of translation and implicate the cap-binding protein eukaryotic initiation factor 4E as a molecular target.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287976      PMCID: PMC1287990          DOI: 10.1073/pnas.0506482102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Internal ribosome entry sites in eukaryotic mRNA molecules.

Authors:  C U Hellen; P Sarnow
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

2.  Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation.

Authors:  Kathy Seggerson; Lingjuan Tang; Eric G Moss
Journal:  Dev Biol       Date:  2002-03-15       Impact factor: 3.582

3.  Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells.

Authors:  Yan Zeng; Eric J Wagner; Bryan R Cullen
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

4.  Translation elongation after assembly of ribosomes on the Cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA.

Authors:  Tatyana V Pestova; Christopher U T Hellen
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

5.  Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.

Authors:  Catherine L Jopling; Minkyung Yi; Alissa M Lancaster; Stanley M Lemon; Peter Sarnow
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

6.  The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation.

Authors:  P H Olsen; V Ambros
Journal:  Dev Biol       Date:  1999-12-15       Impact factor: 3.582

7.  Lipoxygenase mRNA silencing in erythroid differentiation: The 3'UTR regulatory complex controls 60S ribosomal subunit joining.

Authors:  D H Ostareck; A Ostareck-Lederer; I N Shatsky; M W Hentze
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

8.  Poly(A)-binding protein interaction with elF4G stimulates picornavirus IRES-dependent translation.

Authors:  Y V Svitkin; H Imataka; K Khaleghpour; A Kahvejian; H D Liebig; N Sonenberg
Journal:  RNA       Date:  2001-12       Impact factor: 4.942

9.  Picornavirus IRESes and the poly(A) tail jointly promote cap-independent translation in a mammalian cell-free system.

Authors:  G Bergamini; T Preiss; M W Hentze
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

Review 10.  Control of developmental timing by micrornas and their targets.

Authors:  Amy E Pasquinelli; Gary Ruvkun
Journal:  Annu Rev Cell Dev Biol       Date:  2002-04-02       Impact factor: 13.827

View more
  223 in total

1.  The decapping activator HPat a novel factor co-purifying with GW182 from Drosophila cells.

Authors:  Elisabeth Jäger; Silke Dorner
Journal:  RNA Biol       Date:  2010-05-14       Impact factor: 4.652

Review 2.  Epigenetic regulation in alcoholic liver disease.

Authors:  Pranoti Mandrekar
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 3.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

4.  Translational inhibition by deadenylation-independent mechanisms is central to microRNA-mediated silencing in zebrafish.

Authors:  Yuichiro Mishima; Akira Fukao; Tomoyoshi Kishimoto; Hiroshi Sakamoto; Toshinobu Fujiwara; Kunio Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

Review 5.  MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship.

Authors:  Amy E Pasquinelli
Journal:  Nat Rev Genet       Date:  2012-03-13       Impact factor: 53.242

6.  The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells.

Authors:  Michael R Epis; Andrew Barker; Keith M Giles; Dianne J Beveridge; Peter J Leedman
Journal:  J Biol Chem       Date:  2011-10-04       Impact factor: 5.157

Review 7.  General principals of miRNA biogenesis and regulation in the brain.

Authors:  Dónal O'Carroll; Anne Schaefer
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 8.  The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC.

Authors:  Marc R Fabian; Nahum Sonenberg
Journal:  Nat Struct Mol Biol       Date:  2012-06-05       Impact factor: 15.369

Review 9.  Mechanisms of control of microRNA biogenesis.

Authors:  Brandi N Davis-Dusenbery; Akiko Hata
Journal:  J Biochem       Date:  2010-09-09       Impact factor: 3.387

Review 10.  Origins and Mechanisms of miRNAs and siRNAs.

Authors:  Richard W Carthew; Erik J Sontheimer
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.